irinotecan,temozolomide
eli lilly
['irinotecan', 'sarcoma', 'temozolomide', 'loxo']
at #asco23, we're presenting a trial in progress for a phase 2 study evaluating the addition of a cdk 4/6 inhibitor to irinotecan + temozolomide in pediatric &amp; adult patients w/ relapsed or refractory #ewingsarcoma. #clinicaltrials see the details here: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK